Yahoo Web Search

  1. William H. “Bill” Robeck

    The Bulletin16 hours ago

    “Bill” Robeck, of Bend, passed away peacefully on November 14, 2017, with his family by his side, from complications of chronic lymphatic leukemia (CLL). A celebration of Bill’s life ...

  2. Boyle, diagnosed with leukemia in training camp, scored on Hockey Fights Cancer night. Ed Mulholland, USA TODAY Sports 16 of 66 Nov. 22: Nashville Predators forward Filip Forsberg celebrates ...

  3. Bradley, who has been fighting acute myeloid leukemia since March, was moved to the ICU Nov. 26 for pneumonia, according to 10TV. Bradley's husband, Jason Bradley-Krauss, said Thursday ...

  4. Romania: Ex-king Michael who ruled during WWII dies at 96

    Atlanta Journal-Constitution7 days ago

    Romania's royal house says former King Michael, who ruled the country during WWII, has died in Switzerland aged 96. The royal house said in a statement that Michael, one of the few surviving ...

  5. Woltz, 78, of Upper Arlington, died on Saturday from chronic lymphocytic leukemia. A Columbus-area resident for most of his life, Woltz joined the Columbus Division of Fire in January ...

  6. Studies have shown that inhibition of polo-like-kinases can lead to tumor cell death, including a Phase 2 study in Acute Myeloid Leukemia (AML) where response rates up to 31% were observed ...

  7. Initial findings from a multi-national open-label phase Ib study of inhibitory drug therapy for relapsed or refractory acute myeloid leukemia (AML) have demonstrated a complete response ...

  8. KANSAS CITY, Mo. -- Some very special kids enjoy a celebration of the Christmas season Saturday. Christmas music and popular movie characters greeted guests at the annual Leukemia & Lymphoma Society holiday party.

  9. BUSINESS WIRE)-- The "Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2017" report has been added to Research and Markets' offering. Chronic Myelocytic ...

  10. MOVERS: (+) BLUE (+30.18%) Phase 1 study of bb2121 with Celgene ( CELG ) showed 94% response rate (+) AKTX (+12.04%) Phase II COBALT trial met its primary endpoint (+) VSTM (+8.78%) Leukemia ...

  1. 34567646 results